CPM Banner

Product

ACCUITIVE

CPM’s ACCUITIVE platform enables the building and analysis of patient data: individual and at cohort level (multimodal and multi-omics), the discovery of prognostic markers, and the suggestion of precision prescription prioritization recommendations to assist clinicians. CPM has developed two independent and proprietary models in-house.

Data modalities: Clinical, Genomics, Transcriptomics, Proteomics, Immunomics & Radiomics

Chrome

Objectives & outcomes:

  • Unimodal analytics, prognostics biomarkers, and signature profiles for cohorts and patients
  • Custom models based on Multimodal signature (MMMO_Sig) and multimodal model prognostic risk score (MMMO_PRS)
  • ACCUITIVE’s MMMO_PRS model is a novel and unique approach that confers flexibility to clinicians for better patient care in real-world settings where the availability of omics data for individual patients is non-uniform. The model has the distinct advantage of accounting for missing data
  • Flexibility to apply MMMO_Sig and MMMO_PRS based on the availability of data for respective modalities for a cohort (single and/or combinations)
  • Precision prescription prioritization simulation outcome for individual patients to assist relative ranking of available therapies based on patient’s omics data to assist clinicians

Salient features:

  • Supports clinical, radiomics, genomics, transcriptomics, proteomics, and immunomics data analysis
  • User-friendly, interactive, and insightful graphical depictions of the results, such as pie charts, survival plots, volcano plots, circular heatmaps, upset plots, etc.
  • Standard survival outcomes in terms of OS, 5-year, and 10-year survival.
  • ACCUITIVE is an enterprise solution with a robust framework that can be applied to other solid tumors.

Demo use case: Breast cancer
Data source: The Cancer Genome Atlas
Business model: Contract services
Please write to us: for details & we will be happy to discuss: accutivebd@citadelpm.io